Spironolactone Tablet, Film Coated
Product Images NDC 68071-3375

4 FDA label images from Nucare Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 68071-3375). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

68071 3375 1

68071 3375 1
Spironolactone 25 mg film-coated tablets label from NuCare Pharmaceuticals, Inc. The label states 120 tablets per bottle. Each tablet contains 25 mg spironolactone USP, described as round, light yellow to yellow with "AD" inscription on one side. Manufactured by Imas Pharmaceuticals Limited, Ahmedabad, India. Includes NDC number 68071-3375-1 and warnings to keep out of reach of children and store at controlled temperature 68-77°F.*
FDA Label Image

Figure 1. Survival By Treatment Group In The Randomized Spironolactone Evaluation Study (Spironolactone Figure 1)

Figure 1. Survival By Treatment Group In The Randomized Spironolactone Evaluation Study (Spironolactone Figure 1)
A Kaplan-Meier survival curve comparing the probability of survival over 48 months for two groups: Spironolactone (n=822) and Placebo (n=841). The y-axis represents probability from 0 to 1, and the x-axis shows time in months. The Spironolactone group shows higher survival probability than the Placebo group, with a log-rank p-value less than 0.001 indicating statistical significance.*
FDA Label Image

Figure 2. Hazard Ratios Of All-cause Mortality By Subgroup In The Randomized Spironolactone Evaluation Study (Spironolactone Figure 2)

Figure 2. Hazard Ratios Of All-cause Mortality By Subgroup In The Randomized Spironolactone Evaluation Study (Spironolactone Figure 2)
A forest plot chart showing hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups comparing Spironolactone versus placebo. Subgroups include age, sex, race, LVEF percentage, heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACEI use, and beta blocker use. The plot visually represents which group benefits more from Spironolactone or placebo based on HR values.*
FDA Label Image

Chemical Structure (Spironolactone Structure Image)

Chemical Structure (Spironolactone Structure Image)
Chemical structure diagram of spironolactone, the active ingredient in Spironolactone 25 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The structure depicts the molecular arrangement of spironolactone including key functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.